Showing results (31-40 of 616) with videos related to
Sort By:
Pageof 62
American Journal of Hematology|August 20, 2019
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason GotlibSeminars in Cancer Biology|August 13, 2004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylateSteven Coutré, Jason GotlibAmerican Journal of Hematology|March 29, 2024
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason GotlibHematology. American Society of Hematology. Education Program|December 4, 2018
The new tool "KIT" in advanced systemic mastocytosisWilliam Shomali, Jason GotlibSeminars in Cancer Biology|February 6, 2004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylateSteven Coutré, Jason GotlibInternational Journal of Molecular Sciences|April 3, 2021
Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT InhibitorsWilliam Shomali, Jason GotlibExpert Review of Hematology|October 27, 2017
Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemiaMarlise R Luskin, Daniel J DeAngeloJournal of Geriatric Oncology|February 22, 2018
How to treat chronic myeloid leukemia (CML) in older adultsMarlise R Luskin, Daniel J DeAngeloLeukemia & Lymphoma|December 30, 2009
Use of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukemia: translating preclinical findings to clinical practiceDaniel J DeAngelo, Eyal C AttarAmerican Journal of Hematology|January 14, 2026
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With Acute Lymphoblastic LeukemiaRyan D Cassaday, Daniel J DeAngeloPageof 62